Thomas Engell-Sørensen1,2, Andreas Rieckmann3,4, Candida Medina5, David da Silva Té5, Amabelia Rodrigues6, Ane Bærent Fisker6,3,7, Peter Aaby6,3, Christian Erikstrup8, Sanne Jespersen6,9, Christian Wejse6,9,10, Bo Langhoff Hønge6,9,8. 1. Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau. thomas.tes@mail.dk. 2. Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark. thomas.tes@mail.dk. 3. Research Center for Vitamins and Vaccines (CVIVA), Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark. 4. Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark. 5. National HIV Programme, Ministry of Health, Bissau, Guinea-Bissau. 6. Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau. 7. OPEN, Odense University Hospital/Institute of Clinical Research, University of Southern Denmark, Odense, Denmark. 8. Department of Clinical Immunology, Aarhus University Hospital, Aarhus, Denmark. 9. Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark. 10. GloHAU, Center for Global Health, School of Public Health, Aarhus University, Aarhus, Denmark.
Abstract
PURPOSE: To estimate the life expectancy (LE) of HIV-infected patients in the West African country Guinea-Bissau and compare it with the background population. METHODS: Using data from the largest HIV outpatient clinic at the Hospital Nacional Simão Mendes in the capital Bissau, a retrospective observational cohort study was performed. The study included patients attending the clinic between June 2005 and January 2018. A total of 8958 HIV-infected patients were included. In the analysis of the background population, a total of 109,191 people were included. LE incorporating loss to follow-up (LTFU) was estimated via Kaplan-Meier estimators using observational data on adult HIV-infected patients and background population. RESULTS: The LE of 20-year-old HIV-infected patients was 9.8 years (95% CI 8.3-11.5), corresponding to 22.3% (95% CI 18.5-26.7%) of the LE of the background population. (LE for 20-year-olds in the background population was 44.0 years [95% CI 43.0-44.9].) Patients diagnosed with CD4 cell counts below 200 cells/µL had a LE of 5.7 years (95% CI 3.6-8.2). No increase in LE with later calendar period of diagnosis was observed. CONCLUSIONS: LE was shown to be markedly lower among HIV-infected patients compared with the background population. While other settings have shown marked improvements in prognosis of HIV-infected patients in recent years, no improvement in Bissau was observed over time (9.8 years (95% CI 7.6-12.2) and 9.9 years (95% CI 7.6-12.1) for the periods 2005-2010 and 2014-2016, respectively).
PURPOSE: To estimate the life expectancy (LE) of HIV-infectedpatients in the West African country Guinea-Bissau and compare it with the background population. METHODS: Using data from the largest HIV outpatient clinic at the Hospital Nacional Simão Mendes in the capital Bissau, a retrospective observational cohort study was performed. The study included patients attending the clinic between June 2005 and January 2018. A total of 8958 HIV-infectedpatients were included. In the analysis of the background population, a total of 109,191 people were included. LE incorporating loss to follow-up (LTFU) was estimated via Kaplan-Meier estimators using observational data on adult HIV-infectedpatients and background population. RESULTS: The LE of 20-year-old HIV-infectedpatients was 9.8 years (95% CI 8.3-11.5), corresponding to 22.3% (95% CI 18.5-26.7%) of the LE of the background population. (LE for 20-year-olds in the background population was 44.0 years [95% CI 43.0-44.9].) Patients diagnosed with CD4 cell counts below 200 cells/µL had a LE of 5.7 years (95% CI 3.6-8.2). No increase in LE with later calendar period of diagnosis was observed. CONCLUSIONS: LE was shown to be markedly lower among HIV-infectedpatients compared with the background population. While other settings have shown marked improvements in prognosis of HIV-infectedpatients in recent years, no improvement in Bissau was observed over time (9.8 years (95% CI 7.6-12.2) and 9.9 years (95% CI 7.6-12.1) for the periods 2005-2010 and 2014-2016, respectively).
Authors: Dlama N Rasmussen; David da Silva Té; Lotte Rodkjaer; Inés Oliveira; Candida Medina; Toke Barfod; Alex L Laursen; Peter Aaby; Morten Sodemann; Christian Wejse Journal: Afr J AIDS Res Date: 2013-07-26 Impact factor: 1.300
Authors: Charlotte Dyrehave; Dlama Nggida Rasmussen; Bo Langhoff Hønge; Sanne Jespersen; Faustino Gomes Correia; Candida Medina; Christian Wejse; Lotte Rodkjaer Journal: J Int Assoc Provid AIDS Care Date: 2015-08-21
Authors: Edward J Mills; Celestin Bakanda; Josephine Birungi; Keith Chan; Nathan Ford; Curtis L Cooper; Jean B Nachega; Mark Dybul; Robert S Hogg Journal: Ann Intern Med Date: 2011-07-18 Impact factor: 25.391
Authors: Jens S Olesen; Sanne Jespersen; Zacarias J da Silva; Amabélia Rodrigues; Christian Erikstrup; Peter Aaby; Christian Wejse; Bo L Hønge Journal: AIDS Date: 2018-06-01 Impact factor: 4.177
Authors: Sabin Nsanzimana; Eric Remera; Steve Kanters; Keith Chan; Jamie I Forrest; Nathan Ford; Jeanine Condo; Agnes Binagwaho; Edward J Mills Journal: Lancet Glob Health Date: 2015-03 Impact factor: 26.763
Authors: Aysel Gueler; André Moser; Alexandra Calmy; Huldrych F Günthard; Enos Bernasconi; Hansjakob Furrer; Christoph A Fux; Manuel Battegay; Matthias Cavassini; Pietro Vernazza; Marcel Zwahlen; Matthias Egger Journal: AIDS Date: 2017-01-28 Impact factor: 4.177
Authors: Gershim Asiki; Georges Reniers; Robert Newton; Kathy Baisley; Jessica Nakiyingi-Miiro; Emma Slaymaker; Ivan Kasamba; Janet Seeley; Jim Todd; Pontiano Kaleebu; Anatoli Kamali Journal: AIDS Date: 2016-01-28 Impact factor: 4.177
Authors: Margaret May; Jonathan A C Sterne; Caroline Sabin; Dominique Costagliola; Amy C Justice; Rodolphe Thiébaut; John Gill; Andrew Phillips; Peter Reiss; Robert Hogg; Bruno Ledergerber; Antonella D'Arminio Monforte; Norbert Schmeisser; Shlomo Staszewski; Matthias Egger Journal: AIDS Date: 2007-05-31 Impact factor: 4.177
Authors: Leigh F Johnson; Joel Mossong; Rob E Dorrington; Michael Schomaker; Christopher J Hoffmann; Olivia Keiser; Matthew P Fox; Robin Wood; Hans Prozesky; Janet Giddy; Daniela Belen Garone; Morna Cornell; Matthias Egger; Andrew Boulle Journal: PLoS Med Date: 2013-04-09 Impact factor: 11.069
Authors: Ane B Fisker; Justiniano S D Martins; Line M Nanque; Andreas M Jensen; Elsi J C Ca; Sebastian Nielsen; Cesario L Martins; Amabelia Rodrigues Journal: Open Forum Infect Dis Date: 2022-09-11 Impact factor: 4.423